Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Meta-Analysis
. 2022 Apr 30:2022:2755246.
doi: 10.1155/2022/2755246. eCollection 2022.

Associations between Serum Interleukins (IL-1 β, IL-2, IL-4, IL-6, IL-8, and IL-10) and Disease Severity of COVID-19: A Systematic Review and Meta-Analysis

Yuanmin Chang  1 , Mengru Bai  1 , Qinghai You  1
Affiliations
Meta-Analysis

Associations between Serum Interleukins (IL-1 β, IL-2, IL-4, IL-6, IL-8, and IL-10) and Disease Severity of COVID-19: A Systematic Review and Meta-Analysis

Yuanmin Chang et al. Biomed Res Int. .

Abstract

Background: To investigate the association between interleukins (IL-1β, IL-2, IL-4, IL-6, IL-8, and IL-10) and the disease severity of coronavirus disease 2019 (COVID-19).

Materials and methods: We systematically searched records investigating the role of interleukins (IL-1β, IL-2, IL-4, IL-6, IL-8, and IL-10) in COVID-19 patients in Web of Science, Pubmed, and Embase through December 2020. Data were extracted and pooled, and the weighted mean difference (WMD) and its 95% confidence interval (CI) were calculated. The funnel plot and the nonparametric trim and fill method were used to visualize and adjust the publication bias.

Results: In total, 61 studies enrolled 14,136 subjects (14,041 patients and 95 healthy subjects) were enrolled in this meta-analysis. Our results showed that serum IL-2, IL-4, IL-6, and IL-10 levels were elevated in COVID-19 patients compared to healthy controls, and IL-6, IL-8, and IL-10 levels were increased in severe COVID-19 cases compared to nonsevere patients. Additionally, the levels of IL-1β, IL-6, and IL-8 were elevated in nonsurvivor patients compared to survivors. For patients in the intensive care unit (ICU), IL-6 and IL-8 levels were increased than that in non-ICU patients.

Conclusions: Elevated levels of IL-6, IL-8, and IL-10 were associated with the disease severity of COVID-19, and elevated levels of IL-1β, IL-6, and IL-8 were related to the prognosis of COVID-19 patients, which could be used to evaluate COVID-19 patients' disease severity and prognosis.

PubMed Disclaimer

Conflict of interest statement

The authors have declared no potential conflicts of interest in this study.

Figures

Figure 1
Figure 1
The Preferred Reporting Items for Systematic Reviews and Meta-Analyses flow chart.
Figure 2
Figure 2
IL-1β levels in COVID-19 patients. A significant difference in IL-1β levels between severe and nonsevere COVID-19 patients was not found (P = 0.33) (a), while IL-1β levels were increased in (b) nonsurvivor patients compared to survivors.
Figure 3
Figure 3
IL-2 levels in COVID-19 patients. The levels of IL-2 were increased in (a) nonsevere and (b) severe COVID-19 patients compared to healthy subjects, while no significant difference in IL-2 levels between (c) severe and nonsevere COVID-19 patients.
Figure 4
Figure 4
IL-4 levels in COVID-19 patients. IL-4 levels were elevated in (a) nonsevere COVID-19 patients compared to healthy subjects, while no significant difference in IL-4 levels between (b) severe patients and healthy controls, as well as between (c) severe and nonsevere COVID-19 patients.
Figure 5
Figure 5
IL-6 levels in COVID-19 patients and healthy controls. No significant difference in serum IL-6 levels between (a) nonsevere COVID-19 patients and healthy controls, while IL-6 levels were elevated in (b) severe patients compared to healthy subjects, and levels of IL-6 were increased in (c) ICU patients compared to non-ICU patients.
Figure 6
Figure 6
IL-6 levels in COVID-19 patients. The serum levels of IL-6 were increased in (a) severe and (b) nonsurvivor patients compared to nonsevere and survivor patients.
Figure 7
Figure 7
IL-8 levels in COVID-19 patients. The levels of IL-8 were increased in (a) ICU, (b) severe, and (c) nonsurvivor COVID-19 patients compared to non-ICU, nonsevere, and survivor patients.
Figure 8
Figure 8
IL-10 levels in COVID-19 patients. The levels of IL-10 were elevated in (a) nonsevere and (b) severe patients compared to healthy controls, while no significant difference between (c) ICU and non-ICU patients, as well as between (e) nonsurvivor and survivor patients. The levels of IL-10 were elevated in (d) severe patients compared to nonsevere patients.
See this image and copyright information in PMC

References

    1. Vandenberg O., Martiny D., Rochas O., van Belkum A., Kozlakidis Z. Considerations for diagnostic COVID-19 tests. Nature Reviews Microbiology . 2021;19(3):171–183. doi: 10.1038/s41579-020-00461-z. - DOI - PMC - PubMed
    1. Liu J., Liu S. The management of coronavirus disease 2019 (COVID-19) Journal of Medical Virology . 2020;92(9):1484–1490. doi: 10.1002/jmv.25965. - DOI - PMC - PubMed
    1. Sahu K. K., Mishra A. K., Lal A. COVID-2019: update on epidemiology, disease spread and management. Monaldi Archives for Chest Disease . 2020;90(1) doi: 10.4081/monaldi.2020.1292. - DOI - PubMed
    1. Eurosurveillance Editorial Team. Note from the editors: World Health Organization declares novel coronavirus (2019-nCoV) sixth public health emergency of international concern. Euro Surveillance . 2020;25(5) doi: 10.2807/1560-7917.ES.2020.25.5.200131e. - DOI - PMC - PubMed
    1. Mohamadian M., Chiti H., Shoghli A., Biglari S., Parsamanesh N., Esmaeilzadeh A. COVID-19: virology, biology and novel laboratory diagnosis. The Journal of Gene Medicine . 2021;23(2, article e3303) doi: 10.1002/jgm.3303. - DOI - PMC - PubMed